Collectively, BCHE exhibited potent anti-BC efficacy in vitro and in vivo via the induction of ferroptosis mediated by increased Transferrin expression and the intracellular accumulation of Fe2+, as well as decreased GPX4 expression and the upregulation of ROS-induced lipid peroxidation in BC cells. This evidence concerns the gene TF and breast cancer.